Honest Co. director Andrea Turner sells $338,072 in stock By Investing.com

Andrea Turner, a director at Honest Company, Inc. (), recently sold shares of the company’s common stock totaling $338,072. The transactions occurred between August 10 and August 11, 2026, with prices ranging from $5.21 to $5.3 per share. The sales come as the stock has surged 34% over the past week and 144% over six months, though InvestingPro analysis suggests the company is currently overvalued relative to its Fair Value.

On August 10, 2026, Turner disposed of 34,396 shares of common stock. The shares were sold at a weighted average price of $5.3, with individual transaction prices ranging from $5.24 to $5.46. Following this transaction, Turner directly held 282,304 shares, which includes 92,936 restricted stock units payable in an equivalent number of shares of the issuer’s common stock.

The following day, August 11, 2026, Turner sold an additional 29,899 shares of common stock. These shares were sold at a weighted average price of $5.21, with individual transaction prices ranging from $5.19 to $5.25. After this sale, Turner’s direct beneficial ownership stood at 252,405 shares, also including the 92,936 restricted stock units. InvestingPro subscribers have access to 16 additional exclusive tips for HNST, plus comprehensive Pro Research Reports covering this and 1,400+ other US equities.

In other recent news, The Honest Company reported strong second-quarter earnings, with revenue rising to $83.3 million and record margins achieved. The company has also updated its full-year guidance, projecting 2026 revenue between $319 million and $325 million and adjusted EBITDA between $23 million and $25 million. These results have been bolstered by organic revenue growth of nearly 7%. In light of these developments, Freedom Broker has upgraded Honest’s stock rating from Hold to Buy, raising the price target to $5.00 from $4.00. Analyst Balzhan Tleuzhanova highlighted the company’s stronger revenue and profitability, attributing success to momentum in higher-growth product categories. These recent developments have shifted investor focus toward the company’s improved cash flow and profitability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.